This whole cultivated meat industry is “transformative.” But it has to go in steps, Uma Valeti explained.
Here’s a roundup of this week’s stories and some notable news we weren’t able to cover.
U.S. regulators approved both Upside Foods and Good Meat to sell their cultivated chicken products within the country.
“Is cell-culture meat ready for prime time?” wasn’t just a clever TechCrunch+ headline, but a legitimate question posed in early 2022 that still really hasn’t been answered.
The FDA sent a letter to Upside Foods concluding that it had “no further questions” related to its cell-based, chicken-making process.
After five years of research, Meati Foods is poised to begin shipping its plant-based meat product later this year.
While much of the recent capital has targeted the consumer-facing, or downstream side, the firm believes future investments will go into technologies closer to the farm or lab.
Pending regulatory review, the company’s chicken product will be available to consumers in the U.S. later this year.
Cell-cultured meat is a hot topic, yet the process for producing meat in this manner remains slow and costly.